Atlas Trials

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Clinical trial NCT01488877 · TERMINATED

Trial details

NCT number
NCT01488877
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetic Nephropathy
Start date
2012-01-01
Primary completion
2012-07-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.